Intraperitoneal immunotherapy to prevent peritoneal carcinomatosis in patients with advanced gastrointestinal malignancies

Journal of Surgical Oncology

Volumn 100, Issue 4, 2009, Pages 329-330

  Ströhlein, Michael A ^a   Heiss, Markus M ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Immunotherapy; Intraperitoneal treatment; Peritoneal carcinomatosis; Trifunctional antibody

Indexed keywords

CATUMAXOMAB;

ADVANCED CANCER; ASCITES TUMOR; CANCER PREVENTION; CANCER STAGING; CANCER SURGERY; CARCINOMATOUS PERITONITIS; CONFERENCE PAPER; DIGESTIVE SYSTEM CANCER; DRUG MECHANISM; HUMAN; IMMUNOTHERAPY; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA; T LYMPHOCYTE; TUMOR CELL;

ANTIBODIES, MONOCLONAL; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOTHERAPY; PERITONEAL NEOPLASMS;

EID: 69749117809     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21338     Document Type: Conference Paper

References (16)

1. Kunisaki C, Akiyama H, Nomura M, et al.: Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: A multi-institutional study. Ann Surg Oncol 2006;13:659-667.
2. D'Angelica M, Gonen M, Brennan MF, et al.: Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 2004;240:808-816. (Pubitemid 39425773)
3. Jansen M, Buchin P, Dreuw B, et al.: Prognostic factors for development of peritoneal carcinosis in stomach carcinoma. Chirurg 2001;72:561-565.
4. Sugarbaker PH, Yu W, Yonemura Y: Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: The evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol 2003;21:233-248. (Pubitemid 37521721)
5. Glehen O, Mohamed F, Gilly FN: Peritoneal carcinomatosis from digestive tract cancer: New management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 2004;5:219-228. (Pubitemid 38391217)
6. Detroz B, Laurent S, Honore P, et al.: Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis. Acta Chir Belg 2004;104:377-383. (Pubitemid 39277699)
7. Kubicka U, Olszewski WL, Tarnowski W, et al.: Normal human immune peritoneal cells: Subpopulations and functional characteristics. Scand J Immunol 1996;44:157-163. (Pubitemid 26246735)
8. Broche F, Tellado JM: Defense mechanisms of the peritoneal cavity. Curr Opin Crit Care 2001;7:105-116.
9. Lindhofer H, Menzel H, Gunther W, et al.: Bispecific antibodies target operationally tumor-specific antigens in two leukemia relapse models. Blood 1996;88:4651-4658. (Pubitemid 26419149)
10. Ruf P, Lindhofer H: Induction of a long-lasting antitumor immunity by a trifunctional bispecific antibody. Blood 2001;98:2526-2534.
11. Zeidler R, Reisbach G, Wollenberg B, et al.: Simultaneous activation of T cells and accessory cells by a new class of intact bispecific antibody results in efficient tumor cell killing. J Immunol 1999;163:1246-1252. (Pubitemid 29352740)
12. Heiss MM, Strohlein MA, Jager M, et al.: In vivo efficacy of trifunctional bispecific antibodies in treatment of symptomatic malignant ascites. Annual Meeting Proceedings ASCO 2003, Vol.173, 2003.
13. Heiss MM, Strohlein MA, Jager M, et al.: Immunotherapy of malignant ascites with trifunctional antibodies. Int J Cancer 2005;117:435-443. (Pubitemid 41429567)
14. Parsons SL, Murawa PX, Kolesnik OO, et al.: Treatment of epithelial cancer patients with malignant ascites using catumaxomab: Results of the non-ovar stratum of a phase II/III study. The 2008 Gastrointestinal Nancers Symposium Proceedings, 121 25-1-2008. American Society of Clinical Oncology.
15. Parsons SL, Murawa PX, Koralewski P, et al.: Treatment of ovarian cancer patients with malignant ascites using the trifunctional antibody catumaxomab: Results of a phase II/III study. J Clin Oncol 2008;25:5520.
16. Strohlein MA, Gruetzner KU, Tarabichi A, et al.: Efficacy of intraperitoneal treatment with the trifunctional antibody catumaxomab in patients with GI-tract cancer and peritoneal carcinomatosis: A matched pair analysis. J Clin Oncol 2006;24:111.